Key Breast Cancer Updates from Recent SERENA-6 and ASCENT-04 Trials

Liver-Directed Malignancies in Kentucky

With a focus on improving access and modernizing surgical techniques, this episode covers how the hepatic artery infusion (HAI) pump is transforming the landscape for patients with liver-directed malignancies in Kentucky. Host Dr. Zach Pulliam, Medical Oncology Fellow at University of Louisville, speaks with expert Dr. Michael Cavnar from the University of Kentucky Markey Cancer Center to discuss the history, clinical benefits, and new accessibility trials for HAI pump therapy. The conversation focuses on the logistics of rural cancer care, survival benefits for colorectal liver metastases and cholangiocarcinoma, and the future of home-based chemotherapy infusion. Host: Zach Pulliam, MD, [https://www.linkedin.com/in/zachary-pulliam-1306ba126] Guest: Michael Cavnar, MD [https://ukhealthcare.uky.edu/researchers-doctors/michael-cavnar] The Kentucky Society of Clinical Oncology (KYSCO) [https://www.kysco-oncology.org/] blawrence@kysco-oncology.org [blawrence@kysco-oncology.org]

Latest on Hepatic Arterial Infusion Pump Therapy

This episode explores the latest advancements in hepatic arterial infusion (HAI) pump therapy and its impact on cancer care in Kentucky. Surgical Oncologist Brent Xia, MD of the St. Elizabeth Cancer Center, discusses the multidisciplinary effort required to implement this technology and its role in providing targeted, high-dose chemotherapy for liver-directed The conversation highlights the survival benefits of regional therapy, the importance of multidisciplinary tumor boards, and new ways to reduce financial toxicity for patients. Host: Andrew Hearn, MD [https://www.mystfrancis.com/internal-medicine-residency-program/our-residents-im], Hematology & Oncology Fellow, University of Louisville Guest: Brent Xia MD [https://www.stelizabeth.com/providers/bio/brent-xia/] Surgical Oncologist, St. Elizabeth Healthcare / The Yung Family Cancer Center The Kentucky Society of Clinical Oncology (KYSCO) [https://www.kysco-oncology.org/] https://www.interaoncology.com/patients-caregivers/find-an-hai-center [https://url.us.m.mimecastprotect.com/s/coFvCwplAlU91kJAsVf8HJuHc7?domain=interaoncology.com] blawrence@kysco-oncology.org [blawrence@kysco-oncology.org]

Focus on Small Cell Lung Cancer Treatment in Kentucky

With a focus on improving access and managing toxicity, this episode covers how new therapies are transforming the landscape for small cell lung cancer patients across the state. Host Dr. Shreyas Kalantri, Hematology and Oncology Chief Fellow at University of Louisville, speaks with experts Dr. Goetz Kloecker and Dr. Firas Badin to discuss groundbreaking trials and treatment advances for small cell lung cancer like the IMforte and DeLLphi-304 studies. The conversation focuses on real-world implications, survival benefits, and the future of cancer care in Kentucky. Host: Dr. Shreyas Kalantri [https://www.linkedin.com/in/shreyaskalantrimd/] Guest: Dr. Goetz Kloecker [https://uoflhealth.org/provider/goetz-kloecker-cancer-care/] Guest: Dr. Firas Badin [https://www.baptisthealth.com/providers/firas-b-badin-md-hematology-oncology] The Kentucky Society of Clinical Oncology (KYSCO) [https://kysco.accc-cancer.org/] Email: blawrence@accc-cancer.org

Transforming Lung Cancer Care in Kentucky

In the latest episode of KYSCO Oncology Voices, host Dr. Shreyas Kalantri, Hematology and Oncology Chief Fellow at University of Louisville, shares updates on recent advances in non-small cell lung cancer (NSCLC) with renowned experts Dr. Goetz Kloecker and Dr. Firas Badin. They cover landmark trials such as CheckMate 816 (neoadjuvant immunotherapy) and NeoADAURA (neoadjuvant targeted therapy for EGFR-mutant NSCLC), discussing their implications on practice and the multidisciplinary approach to lung cancer care in Kentucky. With Kentucky having one of the highest lung cancer incidence rates, this episode focuses on how recent trial findings can shape patient outcomes in our state. Tune in to explore how cutting-edge research is being translated into real-world clinical practices. Host: Dr. Shreyas Kalantri [https://www.linkedin.com/in/shreyaskalantrimd/] Guest: Dr. Goetz Kloecker [https://uoflhealth.org/provider/goetz-kloecker-cancer-care/] Guest: Dr. Firas Badin [https://www.baptisthealth.com/providers/firas-b-badin-md-hematology-oncology] The Kentucky Society of Clinical Oncology (KYSCO) [https://kysco.accc-cancer.org/] Email: blawrence@accc-cancer.org

Key Breast Cancer Updates from Recent SERENA-6 and ASCENT-04 Trials

Are you up-to-date with the latest breast cancer advances? In the latest episode of KYSCO Oncology Voices, host Dr. Matthew Kurian discusses key breast cancer updates from ASCO 2025 with guest experts Dr. Brian Dong and Dr. Ruta Arays. They explore trial results, including SERENA-6 and ASCENT-04, and their potential implications for treatment decisions in Kentucky. Tune in to understand how these updates might impact both academic and community settings, focusing on the specific challenges faced in Kentucky. Host: Dr. Matt Kurian [https://www.linkedin.com/in/matthew-kurian-md-097aa1216/] Guest: Dr. Ruta Arays [https://ukhealthcare.uky.edu/doctors/ruta-arays] Guest: [https://uoflhealth.org/provider/brian-dong-medical-oncology/] Dr. Brian Dong [https://uoflhealth.org/provider/brian-dong-medical-oncology/] The Kentucky Society of Clinical Oncology (KYSCO) [https://kysco.accc-cancer.org/] Email: blawrence@accc-cancer.org